Document Detail


Fetal neurosurgery: current state of the art.
MedLine Citation:
PMID:  21709818     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Congenital CNS abnormalities have been targets for prenatal intervention since the founding of fetal surgery 30 years ago, but with historically variable results. Open fetal neurosurgery for myelomenigocele has demonstrated the most promising results of any CNS malformation. Improvements in the understanding of congenital diseases and in fetal surgical techniques have reopened the door to applying fetal surgery to other congenital CNS abnormalities. Advances in gene therapy, bioengineering and neonatal neuroprotection will aid in the future expansion of fetal neurosurgery to other CNS disorders.
Authors:
Payam Saadai; Timothy Runyon; Diana L Farmer
Related Documents :
8059548 - Longitudinal fetal biometry of normal pregnant melanesian papua new guineans to constru...
8372678 - Indices of body proportionality in neonates.
9871988 - Estimation of stature from somatometry of skull.
20540658 - The performance of second trimester long bone ratios for down syndrome screening is inf...
23682598 - Impact of risk factors on hypertensive disorders in pregnancy, in primiparae and multip...
16171728 - Reproductive and obstetric characteristics of adolescent pregnancies in turkish women.
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Future neurology     Volume:  6     ISSN:  1748-6971     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-6-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101278119     Medline TA:  Future Neurol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  165-171     Citation Subset:  -    
Affiliation:
Fetal Treatment Center, UCSF Benioff Children's Hospital, 513 Parnassus Ave, HSW-1601, Box 0570, San Francisco, CA 94143-0570, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
U10 HD041669-05//NICHD NIH HHS; U10 HD041669-05S1//NICHD NIH HHS; U10 HD041669-05S2//NICHD NIH HHS; U10 HD041669-05S3//NICHD NIH HHS; U10 HD041669-05S4//NICHD NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.
Next Document:  Analysis of Histone Exchange during Chromatin Purification.